Locally Advanced Rectal Cancer in A Patient With Ectopic Kidney: Case Report And Literature Review
Jun 02, 2022
For more info. contact david.wan@wecistanche.com
Abstract
The coexistence of ectopic kidneys with locally advanced rectal cancer is rare. It poses a surgical and oncological challenge for the treating team. Careful preoperative surgical planning and decision about the neoadjuvant treatment are paramount report a 40. year-old male newly diagnosed with rectal adenocarcinoma with ectopic kidney. His preoperative staging was T3N2MO with ectopic malrotated left kidney. After discussion in the multi-disciplinary team meeting, the decision was to omit the neoadjuvant treatment and to go for low anterior resection.

Click here to learn more about Cistanche
The procedure started open, and the findings showed the kidney lying in the retroperitoneum around 3 cm above the peritoneal reflection and was separable from the tumor, Oncological resection of the rectosigmoid colon by lateral to medial approach with separation and preservation of the kidney, an end-to-end stapler anastomosis followed with a protective loop ileostomy. The patient had a smooth postoperative course, and the final pathology was T3N1Mx. He received eight cycles of adjuvant XELOX and was free of diseases on 1-year follow-up. There is no optimal option in managing this scenario due to a highly variable blood supply of the ectopic kidney and the rarity of this condition. Multi-disciplinary team meeting with preoperative radiological mapping and patient counseling is crucial in making the best decision.

INTRODUCTION
An ectopic kidney is a failure of migration of the kid-ney to it is normal position during the fetal development; instead, it remains in the pelvis. The incidence of this condition is reported to be one in 2100-3000 cases making it a rare condition [1,2. It is estimated that the incidence of rectal cancer is 44180 in the United States in 2019 [3]. The coexistence of ectopic kidney with rectal cancer makes the condition more complex in surgical planning and the need for radiotherapy in locally advanced diseases. Here in this case report, we present a case of an ectopic kidney with a locally advanced rectal cancer (T3N1MO) along with discussing the importance of perioperative management and surgical planning.

Figure 3.MRI pelvis (sagittal view)showed upper rectal mass with mesorectal fat involvement (arrowhead) and ectopic pelvic kidney (arrow).
CASE REPORT
A 40-year-old male, deaf and mute presented with 4 months history of bleeding per rectum associated with a change in bowel movements, and there was no abdominal pain, no history of weight loss, and no family history of colorectal cancer, no the history of tobacco use. On clinical assessment, he looked pale with normal vital signs and his examination showed a soft abdomen, no tenderness or palpable masses per rectal exam revealed blood but no palpable tumor. The basic lab investigation showed an Hgblevel of 8.6g/dL. and CEA level of 4.8 ng/ml. On further investigation, a colonoscopy revealed a large friable fungating circumferential rectal mass at 9 cm from the anal verge extending to the distal sigmoid colon, it was nonobstructing with a length of 8 cm and the rest of the colon was normal. A biopsy from the mass was taken and showed invasive moderately differentiated adenocarcinoma. On further routine of radiological staging, CT of the chest, abdomen, and pelvis confirmed the upper rectal mass with ectopic malrotated left kidney located in the lower abdomen and upper pelvis, opposite to L5-S1 vertebral bodies (Figs 1 and 2). There was no peritoneal disease or distant metastasis. Moreover, the MRI pelvis showed again an upper rectal mass with mesorectal fat invasion and multiple lymph nodes (T3N2) and confirmed an ectopic left kidney (Figs 3 and 4).

The case was discussed in a multi-disciplinary meeting and the decision was to omit the neoadjuvant radiotherapy due to the location of the kidney and to go for upfront surgery then adjuvant chemotherapy. An open low anterior resection was carried on from the beginning and intraoperative findings showed the left ectopic kidney lying around 3 cm above the peritoneal reflection in the retroperitoneal space and it was separated from the tumor. The procedure continued with lateral to the medial mobilization of the colon, separating the kidney from the tumor, followed by oncological resection of the rectosigmoid with ligation of the inferior mesenteric artery and veins. The bowel continuity was restored with stapler end-to-end anastomosis and a protective loop ileostomy was created by the end of the procedure. The patient had a smooth postoperative course and was discharged from the hospital on Day 5 post-operatively. On further follow-up, the histopathology of the resected specimen showed a pT3N1Mx tumor and adjuvant chemotherapy with eight cycles of XELOX was given as recommended by the treating oncologist. His loop ileostomy was revered 12 weeks postoperatively without complications. On 1 year follow-up, the patient was doing well and free of the disease based on the recommended surveillance.

Figure 1.CTscan of the abdomen and pelvis (sagittal view)showing the upper rectal mass (arrowhead) with ectopic kidney (arrow).
DISCUSSION
There are two main factors of most importance in evaluating a patient with rectal cancer and pelvic kidney. First, the anatomical consideration of the ectopic kidney where it has a highly variable blood supply as described by Dretler et al. [4] In 33 patients,17 had a single artery arising at or just distal to the bifurcation of the aorta, while 12 patient has dual blood supply one from the bifurcation and the other from the common iliac artery, and only 3 had triple blood supply (bifurcation, iliac and hypogastric) and 1 patient only with 4 blood supplying vessels with most of the time the blood vessel enters the kidney anteriorly. However, it has a less variable venous drainage. It is reported to drain mostly to the common iliac and/or distal vena cava vein. This consideration has a great value in properly planning the surgical steps and taking the necessary precaution to prevent complications [2]. This could be achieved by CT scan or angiographic imaging to evaluate the vascular anomaly[5].

Based on the experience of the surgeon and the radiological imaging, it is crucial to put in mind the approach of surgery, either robotic, laparoscopy, or open in regard to the safety, ease of accessibility, and surgeon experience [2, 6].
The second factor is the need for radiotherapy in locally advanced diseases, as it is evident that adding neoadjuvant radiotherapy for those patients has a great impact on controlling local recurrence. In one study, the rates of local recurrence at2 years were2.4% in the group assigned to the neoadjuvant radiotherapy with surgery and 8.2% in the group assigned to surgery alone [7]. For this reason, a multi-disciplinary team (MDT) discussion and patient involvement in making the decision on the available options is paramount.

Figure 4. MRI pelvis (coronal viewjshowed upper rectal mass with mesorectal fat involvement farrowhead) and ectopic pe lic kidney (arrow).
Due to the extreme rarity of this condition, the literature lacks the guidelines for the most suitable management. If a patient has the coexistence of locally advanced rectal cancer and pelvic kidney, there are three described options. First, to proceed with nephrectomy if the preoperative investigations showed a nonfunctioning kidney to avoid complications such as acute and chronic nephritis, and malignant and benign hypertension [1,8]. Second,auto-transplant the kidney to a higher location away from the intended irradiated field; however, this technique is surgically difficult due to short ureter and vascular anomaly, and radiation effect is still a risk [1,9]. The third option is the omission of radiotherapy with a full explanation to the patient of the risk of local recurrence and the need for close follow-up.

CONCLUSION
The coexistence of rectal cancer with ectopic kidneys is a rare challenging scenario. Preoperative imaging and surgical planning are crucial to prevent inadvertent com-plication. Until now, there is no clear consensus regarding the optimal management option. For this reason, the involvement of an MDT meeting and the patient understanding of the complication of the surgical option is important in making the decision. The literature needs more reported cases with long-term follow-up to increase the knowledge in our understanding of this disease entity.
CONFLICT OF INTEREST STATEMENT
The author declares no conflict of interest in this article.
FUNDING
None.
ETHICAL. APPROVAL
No ethical approval is needed as per IRB.






